Pathogenesis of malnutrition in cystic fibrosis, and its treatment

Clinical Nutrition

Volumn 19, Issue 6, 2000, Pages 387-394

  Pencharz, P B ^a   Durie, P R ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Cystic fibrosis; Energy needs; Malnutrition; Nutritional assessment

Indexed keywords

BICARBONATE; BILE ACID; FAT; GLYCOCHOLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; LIPID; PANCREAS ENZYME; PROTEIN; SODIUM CHLORIDE; TAURINE; TAUROCHOLIC ACID; TRIACYLGLYCEROL LIPASE;

ANOREXIA; BASAL METABOLIC RATE; CALORIC INTAKE; CALORIMETRY; CHRONIC DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIET THERAPY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY RESOURCE; FECES ANALYSIS; FEMALE; FOLLOW UP; FOOD ANALYSIS; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; GASTROSTOMY; GLUCOSURIA; HEALTH CARE POLICY; HUMAN; LONG TERM CARE; LUNG FUNCTION; LUNG TRANSPLANTATION; MALE; MALNUTRITION; METABOLIC DISORDER; NUTRITIONAL HEALTH; NUTRITIONAL REQUIREMENT; PATHOGENESIS; PNEUMONIA; REVIEW; VOMITING; WEIGHT REDUCTION;

EID: 0033669816     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.1999.0079     Document Type: Review

References (54)

1. Relative underweight in cystic fibrosis and its prognostic value
2. Growth patterns in children with cystic fibrosis
3. Longitudinal studies in cystic fibrosis
4. Perspectives in cystic fibrosis
5. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto
6. Therapy of cystic fibrosis of the pancreas
7. Cystic fibrosis. A not-so-fatal disease
8. Energy intakes and low-fat diets in children with cystic fibrosis
9. The Consensus Committee Nutritional assessment and management in cystic fibrosis: A consensus report
10. A rational approach to the nutritional care of patients with cystic fibrosis
11. Nutritional management of cystic fibrosis
12. Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency
13. Gastrostomy Feeding
14. Extreme variability of response to enzyme therapy in patients with CF
15. 3-secretion in cystic fibrosis
16. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhea due to cystic fibrosis
17. Taurine improves the absorption of a fat meal in patients with cystic fibrosis
18. A rational approach to meeting macro and micronutrient needs in cystic fibrosis
19. Nutrient intakes of adolescents with cystic fibrosis
20. Dietary intakes of adolescent males and females - Is there a difference?
21. Comparison of macronutrient intake of healthy controls and children with cystic fibrosis on low fat or nonrestricted fat diets
22. Energy needs and growth in children with cystic fibrosis
23. Nutritional strategies in cystic fibrosis: Current issues
24. Gastro-oesophageal reflux and esophagitis in cystic fibrosis
25. Gastroesophageal reflux in patients with cystic fibrosis
26. Incidence of distal intestinal obstruction syndrome in cystic fibrosis
27. Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?
28. Energy needs and nutritional rehabilitation in undernourished adolescents and young adult patients with cystic fibrosis
29. Energy expenditure of patients with cystic fibrosis
30. Increased resting energy expenditure in cystic fibrosis
31. Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis
32. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium
33. Increased energy expenditure in young children with cystic fibrosis
34. Energy expenditure in children with cystic fibrosis
35. Identification of the cystic fibrosis gene: Chromosome walking and jumping
36. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
37. Gene/energy interaction in cystic fibrosis
38. Nutritional rehabilitation increases resting energy expenditure without affecting protein turnover in patients with cystic fibrosis
39. The cystic fibrosis gene and resting energy expenditure
40. Increased energy expenditure in cystic fibrosis is associated with specific mutations
41. Protein turnover and resting energy expenditure in patients with undernutrition and chronic lung disease
42. Effect of salbutamol on resting energy expenditure in patients with cystic fibrosis
43. Assessment of total energy expenditure in free-living patients with cystic fibrosis
44. Nutrition, Immunity and Infection: Mechanisms of Interaction
45. Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis
46. Short-term pulmonary effects of total parenteral nutrition in children with cystic fibrosis
47. Short-term clinical, nutritional, and functional effects of continuous elemental enteral alimentation in patients with cystic fibrosis
48. Long-term parenteral nutrition in cystic fibrosis
49. Prolonged parenteral nutrition for cystic fibrosis patients
50. Chronic jejunostomy feeding with a non-elemental formula in undernourished patients with cystic fibrosis
51. Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis
52. Nutritional rehabilitation in cystic fibrosis: Controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease
53. Percutaneous gastrostomy for enteral feeding
54. Prognostic factors associated with patient survival during nutritional rehabilitation in malnourished children and adolescents with cystic fibrosis